These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19139387)

  • 1. Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans.
    Doshi JA; Zhu J; Lee BY; Kimmel SE; Volpp KG
    Circulation; 2009 Jan; 119(3):390-7. PubMed ID: 19139387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.
    Maciejewski ML; Bryson CL; Perkins M; Blough DK; Cunningham FE; Fortney JC; Krein SL; Stroupe KT; Sharp ND; Liu CF
    Am J Manag Care; 2010 Jan; 16(1):e20-34. PubMed ID: 20059288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of increased copayments on pharmacy use in the Department of Veterans Affairs.
    Stroupe KT; Smith BM; Lee TA; Tarlov E; Durazo-Arvizu R; Huo Z; Barnett T; Cao L; Burk M; Cunningham F; Hynes DM; Weiss KB
    Med Care; 2007 Nov; 45(11):1090-7. PubMed ID: 18049350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence.
    Amin K; Farley JF; Maciejewski ML; Domino ME
    J Manag Care Spec Pharm; 2017 Mar; 23(3):337-345. PubMed ID: 28230447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the association between prescription copayment increases and medication adherence differ by race?
    Wong ES; Maciejewski ML; Liu CF
    J Health Care Poor Underserved; 2013 Aug; 24(3):1317-30. PubMed ID: 23974401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does medication adherence following a copayment increase differ by disease burden?
    Wang V; Liu CF; Bryson CL; Sharp ND; Maciejewski ML
    Health Serv Res; 2011 Dec; 46(6pt1):1963-85. PubMed ID: 21689097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a medication copayment increase in veterans with schizophrenia.
    Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.
    Doshi JA; Li P; Desai S; Marcus SC
    J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications.
    Clark B; DuChane J; Hou J; Rubinstein E; McMurray J; Duncan I
    J Manag Care Pharm; 2014 Feb; 20(2):141-50. PubMed ID: 24456315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiered Pharmacy Copayments for Medications. Final rule.
    Department of Veterans Affairs
    Fed Regist; 2016 Dec; 81(238):89383-91. PubMed ID: 28000499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Outcome Changes in Individuals With Type 1 Diabetes After a State-Level Insulin Copayment Cap.
    Giannouchos TV; Ukert B; Buchmueller T
    JAMA Netw Open; 2024 Aug; 7(8):e2425280. PubMed ID: 39141389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study.
    Watanabe JH; Kazerooni R; Bounthavong M
    J Manag Care Pharm; 2014 Jan; 20(1):43-50. PubMed ID: 24372459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copayments for medications after June 30, 2010. Final rule.
    Department of Veterans Affairs
    Fed Regist; 2011 Feb; 76(35):9646-8. PubMed ID: 21351679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.
    Dusetzina SB; Huskamp HA; Winn AN; Basch E; Keating NL
    JAMA Oncol; 2018 Jun; 4(6):e173598. PubMed ID: 29121177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 Diabetes.
    Taber DJ; Ward R; Axon RN; Walker RJ; Egede LE; Gebregziabher M
    Ann Pharmacother; 2019 Jul; 53(7):675-682. PubMed ID: 30724092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copayments for medications in 2013. Interim final rule.
    Department of Veterans Affairs
    Fed Regist; 2012 Dec; 77(250):76865-7. PubMed ID: 23285514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copayments for medications after June 30, 2010. Interim final rule.
    Department of Veterans Affairs
    Fed Regist; 2010 Jun; 75(110):32670-3. PubMed ID: 20533616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of copayment and socioeconomic status with hormonal contraceptive adherence in a female veteran population.
    Kazerooni R; Vu K; Takizawa A; Broadhead C; Morreale AP
    Womens Health Issues; 2014; 24(2):e237-41. PubMed ID: 24533983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial.
    Fanaroff AC; Peterson ED; Kaltenbach LA; Anstrom KJ; Fonarow GC; Henry TD; Cannon CP; Choudhry NK; Cohen DJ; Atreja N; Bhalla N; Eudicone JM; Wang TY
    Circ Cardiovasc Qual Outcomes; 2020 May; 13(5):e006182. PubMed ID: 32393129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.